Contraceptive Devices Market Size Anticipated to Grow with a Substantial CAGR of 6.71% and Extend to USD 41.84 Billion During the Study Period 2018-26, Examines DelveInsight
October 21, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Contraceptive Devices Market Size Anticipated to Grow with a Substantial CAGR of 6.71% and Extend to USD 41.84 Billion During the Study Period...
Exceptionally Robust Asthma Pipeline with More Than 100+ Pipeline Therapies Propelling the Lung Disease’s Research Sphere Extensively
October 20, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Exceptionally Robust Asthma Pipeline with More Than 100+ Pipeline Therapies Propelling the Lung Disease’s Research Sphere Extensively Asthma is...
Emerging Drugs for the Heart Failure Treatment: A Focus on Recent Clinical Trials | DelveInsight
October 19, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Emerging Drugs for the Heart Failure Treatment: A Focus on Recent Clinical Trials | DelveInsight The pipeline of Heart failure is robust, with...
Seborrhoeic Dermatitis Pipeline: Pipeline Review, Novel and Emerging Therapeutic Drugs, Ongoing Clinical Trials Analysis, and Key Pharma Players| DelveInsight
October 14, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Seborrhoeic Dermatitis Pipeline: Pipeline Review, Novel and Emerging Therapeutic Drugs, Ongoing Clinical Trials Analysis, and Key Pharma Players|...
Propulsion of Malignant Mesothelioma Pipeline as Novel and Extensive Therapies Enter the Treatment Domain, Anticipates DelveInsight
October 13, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Propulsion of Malignant Mesothelioma Pipeline as Novel and Extensive Therapies Enter the Treatment Domain, Anticipates DelveInsight Malignant...
DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape
October 12, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndrome as Influential Pharma Players Set Foot in the MDS Landscape ...
Acne Vulgaris Pipeline: Therapeutic Assessment, Emerging Drugs, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis | DelveInsight
October 11, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Acne Vulgaris Pipeline: Therapeutic Assessment, Emerging Drugs, Key Pharma Players, Clinical Trials, and Growth Prospects Analysis | DelveInsight ...
Metastatic Colorectal Cancer Pipeline Review | Clinical Trials Analysis Report 2021 | DelveInsight
October 06, 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Metastatic Colorectal Cancer Pipeline Review | Clinical Trials Analysis Report 2021 | DelveInsight Metastatic Colorectal Cancer Pipeline is...
Extremely Robust Esophageal Cancer Pipeline Expected to Change the Pace of Cancer Treatment as Many Critical Pharma Companies are Proactively Participating in Developing Novel Therapies Estimates DelveInsight
October 05, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Extremely Robust Esophageal Cancer Pipeline Expected to Change the Pace of Cancer Treatment as Many Critical Pharma Companies are Proactively...
Epilepsy Pipeline: Insights into Novel and Emerging Pipeline Therapies, Key Pharma Players, Clinical Trials, Growth Prospects, and Treatment Landscape | DelveInsight
October 04, 2021 20:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Epilepsy Pipeline: Insights into Novel and Emerging Pipeline Therapies, Key Pharma Players, Clinical Trials, Growth Prospects, and Treatment...